The role of stress in perinatal depression and anxiety - A systematic review

Front Neuroendocrinol. 2024 Jan:72:101117. doi: 10.1016/j.yfrne.2023.101117. Epub 2024 Jan 3.

Abstract

Perinatal depression (PND) and anxiety affect around 20% of women, but available pharmacotherapy is not sufficiently effective in 20-60% of them, indicating a need for better understanding of these diseases. Since stress is a significant risk factor for PND, the aim was to examine the role of biological, environmental and psychological stress in PND and anxiety through a systematic literature search. Overall 210 studies were included, among which numerous rodent studies showed that perinatal stress induced depressive-like and anxious behavior, which was associated with HPA-axis alterations and morphological brain changes. Human studies indicated that the relationship between cortisol and perinatal depression/anxiety was not as clear and with many contradictions, although social and psychological stress were clearly positively associated with PND. Finally, oxytocin, synthetic neuroactive steroid and n-3 PUFA diet have been identified as potentially beneficial in the therapy of PND and anxiety, worth to be investigated in the future.

Keywords: Anxiety; Corticotropin-releasing factor; Depression; Glucocorticoids; Hypothalamo-Hypophyseal System; Postpartum depression; Pregnancy; Psychological stress Puerperal disorders; Puerperium.

Publication types

  • Systematic Review
  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anxiety
  • Anxiety Disorders
  • Brain
  • Depression* / etiology
  • Depressive Disorder*
  • Female
  • Humans
  • Hypothalamo-Hypophyseal System
  • Pituitary-Adrenal System
  • Pregnancy
  • Stress, Psychological / complications
  • Stress, Psychological / psychology